There is a protein recognized as a biomarker for inherited Parkinson’s disease, and precise quantification is a critical component for developing targeted therapies. This requires innovative methodologies to capture the sensitive changes in protein levels, considering the naturally high levels in normal human cerebrospinal fluid.
Check out our poster to learn more about how we were able to:
